Brookstone Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Brookstone Capital Management's BSX Position: Q3 2026 in Review
Brookstone Capital Management reduced its Boston Scientific (BSX) stake by 11% in Q3 2026, selling an estimated $85.1K and leaving 14,946 shares worth $652K. The position accounts for 0.01% of the portfolio, ranked #843.
Brookstone Capital Management first reported a position in BSX in Q2 2015 and has held it in 19 quarters since. The position peaked at $17.5M in Q4 2025. 1,514 funds tracked by Wall St. Rank hold BSX as of Q3 2026.
- Brookstone Capital Management held 14,946 shares of Boston Scientific worth $652K as of Q3 2026.
- Brookstone Capital Management sold 1,837 Boston Scientific shares in Q3 2026, an estimated $85.1K.
- Boston Scientific made up 0.01% of Brookstone Capital Management's portfolio in Q3 2026, its #843 holding.
- Brookstone Capital Management first reported a position in Boston Scientific in Q2 2015 and has held it in 19 quarters since.
- Brookstone Capital Management's Boston Scientific position peaked at $17.5M in Q4 2025.
- 1,514 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.
Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.